Main Line Equity Partners Acquires Cianflone Scientific Instruments Corp Transaction will significantly enhance new business with current and future customers Main Line Equity Partners today announced the acquisition of Cianflone Scientific Instruments Corp., a global...
Main Line Equity Partners Invests in Converge HR Solutions The growth capital will enable converge to seize new market opportunities and increase profitability Main Line Equity Partners has announced a new investment in Converge HR Solutions, a strategic Human...
Main Line Equity Partners Invests in C2 Therapeutics Growth capital to help developer of ablation therapies improve its preventive treatment of esophagus cancer Main Line Equity Partners today announced it has made an investment in C2 Therapeutics, a privately held...
Main Line Equity Partners Investment Company Sapheon Acquired by Covidien Transaction expands product suite for global healthcare leader with next generation technology for treatment of varicose veins Sapheon, a developer and manufacturer of venous disease treatments...
Main Line Equity Partners Invests in InfoMC Growth capital to help advance product development and sales for provider of clinical and financial management software InfoMC, the leading provider of clinical and financial management software for chronic illness care...
Main Line Equity Partners Invests in Matrix Solutions Growth capital to expand services and management buyout for media-specific CRM and data analytics leader Matrix Solutions, the leading provider of Media CRM and Sales Analytics, has received an investment from Main...
